March 6, 2020 / 12:33 PM / 25 days ago

BRIEF-Shanghai Fosun Pharmaceutical Updates On Approval For Drug Clinical Trial

March 6 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd:

* UNIT’S FCN-207 TABLET ACCEPTED FOR CLINICAL TRIAL & REGISTRATION REVIEW OF NATIONAL MEDICAL PRODUCTS ADMINISTRATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below